Use of fast‐acting insulin aspart in insulin pump therapy in clinical practice

Fast‐acting insulin aspart (faster aspart) is a novel formulation of insulin aspart (IAsp) containing the additional excipients niacinamide and L‐arginine. The improved pharmacological profile and greater early glucose‐lowering action of faster aspart compared with IAsp suggests that faster aspart m...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Obes Metab
Hlavní autoři: Evans, Mark, Ceriello, Antonio, Danne, Thomas, De Block, Christophe, DeVries, J. Hans, Lind, Marcus, Mathieu, Chantal, Nørgaard, Kirsten, Renard, Eric, Wilmot, Emma G.
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2019
Témata:
Review Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6773364/
https://ncbi.nlm.nih.gov/pubmed/31144428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13798
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky